Habib Ramdani - Virbac SA CFO, Member of the Management Board
| VRBCF Stock | | | USD 346.00 0.00 0.00% |
CFO
Mr. Habib Ramdani was Financial Director and Member of the Management Board of Vibrac SA since 2016. He is currently also Director of Asia Pharma Limited, Chairman of Interlab and representative of Virbac at Virbac Chile Soa, among others. Mr. Ramdani is graduate of Ecole Centrale de Paris. since 2016.
| Age | 46 |
| Tenure | 9 years |
| Phone | 33 4 92 08 71 00 |
| Web | https://corporate.virbac.com |
Virbac SA Management Efficiency
The company has return on total asset
(ROA) of
0.091 % which means that it generated a profit of $0.091 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
0.1542 %, meaning that it generated $0.1542 on every $100 dollars invested by stockholders. Virbac SA's management efficiency ratios could be used to measure how well Virbac SA manages its routine affairs as well as how well it operates its assets and liabilities.
Virbac SA has accumulated 13.15
M in total debt with debt to equity ratio
(D/E) of 0.14, which may suggest the company is not taking enough advantage from borrowing. Virbac SA has a current ratio of 1.65, which is within standard range for the sector. Debt can assist Virbac SA until it has trouble settling it off, either with new capital or with free cash flow. So, Virbac SA's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Virbac SA sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Virbac to invest in growth at high rates of return. When we think about Virbac SA's use of debt, we should always consider it together with cash and equity.
Similar Executives
Virbac SA manufactures and sells a range of products and services for companion and food-producing animals in France, Europe, Latin America, North America, the Asia Pacific, the Middle East, and Africa. Virbac SA was founded in 1968 and is headquartered in Carros, France. Virbac Sa operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 5120 people. Virbac SA [VRBCF] is a
Pink Sheet which is traded between independent brokers as part of over-the-counter (OTC) trading.
Management Performance
Virbac SA Leadership Team
Elected by the shareholders, the Virbac SA's board of directors comprises two types of representatives: Virbac SA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Virbac. The board's role is to monitor Virbac SA's management team and ensure that shareholders' interests are well served. Virbac SA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Virbac SA's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Nathalie Pollet, Head Devel | |
| Marc Bistuer, Head CEO | |
| Sandrine Brunel, Head Communications | |
| Bertrand Havrileck, Biologicals RD | |
| Sebastien Huron, Area Director Europe, Member of the Management Board | |
| Habib Ramdani, CFO, Member of the Management Board | |
| Manuela Rodrguez, Director Projects | |
| Christian Karst, Executive Vice-Pres for Corporate Devel., General Manager, Member of the Executive Board and Member of Strategic Committee | |
| Francesca Cortella, Head HR | |
| Sophie Favini, Head Operations | |
Virbac Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Virbac SA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Currently Active Assets on Macroaxis
Other Information on Investing in Virbac Pink Sheet
Virbac SA financial ratios help investors to determine whether Virbac Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Virbac with respect to the benefits of owning Virbac SA security.